Impact of revascularization on clinical outcomes
| Trial and Clinical Outcomes at 90 days | Recanalized Patients (%) | Nonrecanalized Patients (%) | P Value |
|---|---|---|---|
| MERCI | |||
| mRS ≤2 | 46 | 10.4 | <.0001 |
| Mortality | 31.8 | 54.2 | .0101 |
| Multi MERCI | |||
| mRS ≤2 | 49.1 | 9.6 | <.001 |
| Mortality | 24.8 | 51.9 | <.001 |
| Penumbra | |||
| mRS ≤2 | 29 | 9 | .0596 |
| Mortality | 29 | 48 | .1384 |
| IMS I-II | |||
| mRS ≤2 | 45.6 | 6.9 | .0004 |
| Mortality | 10.9% | 34.5 | .01 |